| Date |
Report No. |
Title |
| Date May 9, 1997 |
Report No. NSIAD-97-148BR |
Title
United States General Accounting Office GAO
May 1997 Briefing Report to the Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL U.S. Heroin Control Efforts in Southwest Asia and the Former Soviet Union GAO/NSIAD-97-148BR GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-276822 May 9, 1997 The Honorabl... |
| Date April 15, 1997 |
Report No. AA-97-14(2) |
Title
|
| Date Jan. 2, 1997 |
Report No. AA-97-14(1) |
Title
United States General Accounting Office GAO
January 1997 Health, Education and Human Services Division T Health Services
Quality and Public Health Issue Area Active Assignments c GA/A-9-1(1 06OA 2\ A9 1) Foreword This report was prepared primarily to inform Congressional members and key staff of ongoing assignments in the General Accounting Office's Health Services Quality and Public Health issue ... |
| Date Sept. 19, 1996 |
Report No. T-HEHS-96-216 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, September 19, 1996 Testimony
Before the Subcommittee on Oversight and Investigations Committee on Commerce, House of Representatives PRESCRIPTION DRUG PRICING Implications for Retail Pharmacies
Statement of Sarah F. Jaggar, Director Health Services Quality and Public Health Health, Education, and H... |
| Date Sept. 12, 1996 |
Report No. T-HEHS-96-212 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. September 12, 1996 Testimony
Before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U. S. House of Representatives PRESCRIPTION DRUGS Implications of Drug Labeling and Off-Label Use
Statement of Sarah F. Jagger Director of Health Services Qua... |
| Date Sept. 5, 1996 |
Report No. T-HEHS-96-206 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, September 5, 1996 Testimony
Before the Subcommittee on Civil Service Committee on Government Reform and Oversight House of Representatives BLUE CROSS AND BLUE SHIELD Change in Pharmacy Benefits Affects Federal Enrollees
Statement of Sarah F. Jaggar, Director Health Services Quality and Public Health... |
| Date June 11, 1996 |
Report No. T-HEHS-96-162 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Tuesday, June 11, 1996 Testimony
Before the Subcommittee on Hospitals and Health Care, Committee on Veterans’ Affairs, House of Representatives VA HEALTH CARE Opportunities to Reduce Outpatient Pharmacy Costs
Statement of David P. Baine, Director, Health Care Delivery and Quality Issues Health, Education, ... |
| Date Feb. 21, 1996 |
Report No. T-PEMD-96-6 |
Title
United States General Accounting Office Testimony
Before the Committee on Labor and Human Resources U.S. Senate For Release on Delivery Expected at 9~30a.m. EST Wednesday February 2 1,1996 Statement of Mary R. Hamilton, Ph.D. Director of Program Evaluation in the Human Services Area Program Evaluation and Methodology Division GAOfI’ -PEMD-96-6 Dear Madam Chairman: In October 1995, GAO issued a r... |
| Date Feb. 7, 1996 |
Report No. T-HEHS-96-85 |
Title
United States General Accounting Office GAO
For Releaseon Delivery Expectedat 1:00p.m. Wednesday February7.19% Testimony
Before the Committeeon Insurance California StateSenate PHARMACY BENEFIT MANAGERS Early Results on Ventures With Drug Manufacturers
Statementof John C. Hansen,AssistantDirector Health Financing and Public Health Issues Health, Education, and Human ServicesDivision Mr. Chairman a... |
| Date Nov. 9, 1995 |
Report No. HEHS-96-45 |
Title
United States General Accounting Office GAO
November 1995 Report to the Honorable Ron Wyden, House of Representatives PHARMACY BENEFIT MANAGERS Early Results on Ventures With Drug Manufacturers GAO/HEHS-96-45 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-257388 November 9, 1995 The Honorable Ron Wyden House of Representatives De... |
| Date Oct. 20, 1995 |
Report No. PEMD-96-1 |
Title
United States General Accounting Office GAO
October 1995 Report to Congressional Requesters FDA DRUG APPROVAL Review Time Has Decreased in Recent Years GAO/PEMD-96-1 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-266023 October 20, 1995 The Honorable Nancy Landon Kassebaum Chairman The Honorable Edward M. Kennedy Ranking Minority Me... |
| Date Oct. 1, 1995 |
Report No. AA-95-15(4) |
Title
United States General Accounting Office GAO
October 1995 Health, Education and Human Services Division Medicare and Medicaid Issue Area Active Assignments GAO/AA-95-15(4) 0653SR/ At; q F3 Medicare and Medicaid M PAYMENT METHODS E
TITLE MEDICARE COSTS UNDER THE RBRVS SYSTEM (101329) BACKGROUND: In 1992, Medicare stopped paying doctors based on "usual and customary rates." Medicare's new fee schedul... |
| Date Sept. 29, 1995 |
Report No. AIMD-95-169 |
Title
United States General Accounting Office GAO
September 1995 Report to the Chairman, Committee on Ways and Means, House of Representatives MEDICAL LIABILITY Impact on Hospital and Physician Costs Extends Beyond Insurance GAO/AIMD-95-169 GAO United States General Accounting Office Washington, D.C. 20548 Accounting and Information Management Division B-260671 September 29, 1995 The Honorable Bill Arch... |
| Date April 28, 1995 |
Report No. HEHS-95-90 |
Title
United States General Accounting Office 3AO Report to the Chairman, Special Committee on Aging, U.S. Senate Apil 1995 PRESCRIPTION DRUG
PRICES Official Index Overstates Producer Price Inflation GAO/IEHS-95-90 GAO ~~~~~~Washington,D.C. 20548 United States General Accounting Office Health, Education, and Human Services Division B-260293 April 28, 1995 The Honorable William S. Cohen Chairman, Special... |
| Date Jan. 18, 1995 |
Report No. GGD-95-52R |
Title
GAO United States General Accounting Offke Washington, D.C. 20548 General Government Division B-259550 January 18, 1995 Jr. The Honorable F. James Sensenbrenner, House of Representatives Dear Mr. Sensenbrenner: This correspondence responds to your request for information on how certain controlled substances are regulated, particularly methylphenidate-a central nervous system stimulant approved for... |
| Date Dec. 16, 1994 |
Report No. HEHS-95-27 |
Title
United States General Accounting Office GAO
December 1994 Report to the Chairman, Committee on Governmental Affairs, U.S. Senate GERMAN HEALTH REFORMS Changes Result in Lower Health Costs in 1993 GAO/HEHS-95-27 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-254061 December 16, 1994 The Honorable John Glenn Chairman, Committee on ... |
| Date Dec. 15, 1994 |
Report No. HEHS-95-34R |
Title
GAO United States General Accounting Office Washington, D.C. 20648 Health, Education and Human Services Division B-232863 December 15, 1994 The Honorable Tim Valentine, Chairman The Honorable Tom Lewis, Ranking Minority Member The Honorable Peter I. Blute Subcommittee on Technology, Environment and Aviation Committee on Science, Space, and Technology House of Representatives Members of Congress ha... |
| Date Aug. 12, 1994 |
Report No. HEHS-94-200R |
Title
United States General Accounting Offlce WashIngton, D.C. 20548 Health, Education and Human Services Divlslon rn3y/- B-226377 August 12, 1994 The Honorable Henry A. Waxman Chairman, Subcommittee on Health and the Environment Committee on Energy and Commerce House of Representatives Dear Mr. Chairman: As the debate over U.S. health care reform continues, prescription drug prices remain the subject o... |
| Date Aug. 5, 1994 |
Report No. HEHS-94-194FS |
Title
GAO
August 1994 United States General Accounting Office /LJ?Fz24- Fact Sheet for the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives MEDICAID Chmges in Best Price for Outpatient Drugs Purchased by HMOs and Hospitals GAO/EEHS-94-194FS 1 Notice: This is a reprint of a GAO r&d United States General Accounting Office W... |
| Date July 27, 1994 |
Report No. T-HEHS-94-213 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 930 a.m., EST Wednesday July 27, 1994 Testimony
Before the Committee on Governmental Affairs United States Senate PRESCRIPTION DRUGS Prices and Regulation in Canada and Europe
Statement of Sarah F. Jaggar Director, Health Financing and Policy Issues Health, Education, and Human Services Division Messrs. Chairmen and Me... |
| Date July 22, 1994 |
Report No. PEMD-94-26 |
Title
,..
,” . : , ‘. , . I GAO United States General Accounting Office Washiin, D.C. 20648 Program Evaluation and Methodology Division
B-253555 July 221994 The Honorable Edolphus Towns Chairman, Human Resources and Intergovernmental Relations Subcommittee Committee on Government Operations House of Representatives Dear Mr. Chairman: In October 1992, the Congress passed the Prescription Drug User Fe... |
| Date May 17, 1994 |
Report No. HEHS-94-30 |
Title
Health, Education, and Human Services Division B-251111 May 17,1994 The Honorable David H. Pryor Chairman, Special Committee on Aging United States Senate Dear Mr. Chairman: This report, prepared at your request, examines how other countries regulate prescription drug prices, how those policies affect drug prices, and how they affect pharmaceutical research and development. As arranged with your ... |
| Date May 13, 1994 |
Report No. GGD-94-139 |
Title
United States General Accounting Office “GAO ’
May 1994 Report to the Chairman, Special Committee on-Aging, U.S. Senate TAX POLICY Pharmaceutical Industry’ Use of the s Reseafch Tax Credit GAOIGGD-94-139 B-256950 May 13, 1994 The Honorable David Pryor Chairman, Special Committee on Aging United States Senate Dear Mr. Chairman: This report is the second part of a response to your request to r... |
| Date May 6, 1994 |
Report No. HEHS-94-136R |
Title
w-8 Y GAO Washington,D.C.20548
Human Resources Division United States General Accounting Office 1 B-256121 May 6, 1994 The Honorable John D. Dingell Chairman, Committee on Energy House of Representatives The Honorable United States Orrin G. Hatch Senate and Commerce Because of changes over the last few years in the Food and Drug Administration's (FDA) monitoring of generic drug manufacturers,l you... |
| Date Jan. 12, 1994 |
Report No. HEHS-94-29 |
Title
United States General Accounting Office GAO
January 1994 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives ’ PRESCRIPTION DRUGS Companies Qpically Charge More in the United States Than in the United Kingdom GAO United States General Accounting Office Washington, D.C. 20648 Human Health, Education, and Services Division ... |
| Date Oct. 13, 1993 |
Report No. HRD-94-1R |
Title
.GAO United states General Acconnting OfIke Wwhtngton, D.C. 20648 Human Resources Division B-250909 October 13, 1993 The Honorable Fortney H, (Pete) Stark Chairman, Subcommittee on Health Committee on Ways and Means House of Representatives Dear Mr. Chairman:
This letter responds to your request that.we evaluate the methodology and data used by the Health Care Financfng Administration (HCFA) to es... |
| Date Oct. 13, 1993 |
Report No. T-HRD-94-2 |
Title
United States General Accounting OfTice GAO
For Release on Delivery Expected at IO:00 a.m., WedlESday, October 13. 1993 Testimony
Before the Committee on Finance United StatesSenate 1993 GEFUdAN HEALTH REFORMS Initiatives Tighten cost Controls
Statement of Janet L. Shikles, Assistant Comptroller General, Human ResourcesDivision SUMMARY In 1993, Germany, concerned about sharp increases in health in... |
| Date Aug. 2, 1993 |
Report No. HRD-93-118 |
Title
GAO
August 1993 Report to Congressional Requesters MEDICAID DRUG FRAUD Federal Leadership Needed to Reduce Program Vulnerabilities GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-246968 August 2,1993 The Honorable Charles Range1 House of Representatives The Honorable Edolphus Towns Chairman, Subcommittee on Human Resources and Intergovernmental Relatio... |
| Date Aug. 2, 1993 |
Report No. T-HRD-93-28 |
Title
United States General Accounting Office 14qG61 - - * Testimony
Before the Subcommitteeon Human Resourcesand IntergovernmentalRelations, Committee on GovernmentOperations House of Representatives
For Releaseon Delivery Expected at 9:30 a.m. Monday August 2,1993 MEDICAID DRUG FRAUD Federal Leadership Needed to Reduce Program Vulnerabilities
Statementof Leslie G. Aronovitz AssociateDirector, Health F... |
| Date July 7, 1993 |
Report No. HRD-93-103 |
Title
United States General Accounting Office GAO
July 1993 Report to the Chairman, Committee on Governmental Affairs, U.S. Senate 1993 GERMAN
HEALTH REFORMS New Cost Control Initiatives GAO United States General Accounting OfTice Washington, D.C. 20648 Human Resources Division B-262173 July 7, 1993 The Honorable John Glenn Chairman, Committee on Governmental Affairs United States Senate Dear Mr. Chairm... |
| Date April 12, 1993 |
Report No. HRD-93-81 |
Title
IJnited States General Accounting Office Report to Congressional Requesters FDA PREMARKET APPROVAL Process of Approving Lodine as a Drug GAO United States General Accounting Of’ flce Washington, D.C. 20548 Human Resource6 Division B-262669 April 12,1903 The Honorable William J. Hughes Chairman, Subcommittee on Intellectual Property and Judicial Administration Committee on the Judiciary House of ... |
| Date March 18, 1993 |
Report No. HRD-93-55FS |
Title
-I nl;krTll I !Wl MEDICAID Outpatient Drug Costs and Reimbursements for Selected Pharmacies in Illinois and Maryland 14864’ 3 \.. ~- ’ (;Ao/llItI)-!):3-5f,I1’ S - __---___-- - GAO United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-251918 March 18, 1993 The Honorable Daniel P. Moynihan, Chairman The Honorable Bob Packwood, Ranking Minority Member Committ... |
| Date March 11, 1993 |
Report No. T-RCED-93-19 |
Title
\ q u) y) m 1 United States General Accountins Offke Testimony
Before the Subcommitteeon Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives For Relewc on Delivery Expected at 930 p.m. EST lllurs;day March 11, lW3 FEDERALLY FUNDED RESEARCH Controlling Inappropriate Access to ResearchResults
Statementby Jim Wells, AssociateDirector, Energy and S... |
| Date Feb. 22, 1993 |
Report No. T-HRD-93-5 |
Title
United StatesGenerd kmmtinp Office GAO
For Release D&very on Eqwedat 1050 am., EST
Mai&ly Testimony
Before the Subcommitteeon Health and the Environment; Committee on Energy and Commerce, _ House of Representatives PRESCRIPTIONDRUGS CompaniesTypically Charge More in the United States Than in Canada
Statementof Janet L. SWes, Director, Health Financing and Policy Issues, Human ResourcesDivision Fcb... |
| Date Feb. 17, 1993 |
Report No. HRD-93-51 |
Title
PRESCRIPTION DRUG PRICES i 48527 Ill RESTRICTED-Not to be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. I 5Sb’ f58 RELEASED GAO United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-247942 February 17, 1993 The Honorable David Pryor Chairman, Special Committee on Aging United States Senate... |
| Date Jan. 15, 1993 |
Report No. HRD-93-43 |
Title
MEDICAID Changes in Drug Prices Paid by HMOs and Hospitals Since Enactment of Rebate Provisions .,, --. Y
148334 GAO United States General Accounting OMce Washington, D.C. 20548 Human Resources Division B-245873 January 15, 1993 The Honorable Lloyd Bentsen, Chairman The Honorable Bob Packwood, Ranking Minority Member Committee on Finance United States Senate The Honorable John D. Dingell, Chairman... |
| Date Oct. 29, 1992 |
Report No. HRD-93-17 |
Title
IJnited States General Accounting Office Report to Congressional Requesters Octobt?r 1992 WOMEN’ HEALTH S FDA Needs to Ensure More Study of Gender Differences~ in Prescription Drug Testing, II II
147861 GAO/HRD-93-1’ 7 . United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-243898 October 29,1992 The Honorable Henry A. Waxman Chairman, Subcommittee on Health... |
| Date Sept. 30, 1992 |
Report No. HRD-92-110 |
Title
c
lJnited States General Accounting Office GAO
September 1992 Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce; House of Representatives PRESCRIPTION DRUGS Companies Q-pieally Charge More in the United States Than in Canada
,- aESTRICTED--Not to be released outside the General Accounting Offke unless specifically approved by the Office of Congres... |
| Date Aug. 31, 1992 |
Report No. RCED-92-231 |
Title
All~llst. awz CANCER TREATMENT Actions Taken to More Fully Utilize the ESark of Pacific Yews on Federal Land RESTI&ICTEIX-Not to be ?eleas&l~outside ‘the General Accounting Office unless specifically approved by the Offke of Congressional Relations., ” ..-- -.. ._-. I.-...~..I*.. --.-..I..--...-.----_ ..” . . -_-_-_--I -. i m GAO United Statee General Accounting OffIce Washington, D.C. 20648... |
| Date Aug. 24, 1992 |
Report No. HRD-92-128 |
Title
GAO PRl%%?RIPTION DRUGS Changes in Prices for Selected Drugs 147429 RES’rRICTED-Not to. be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. 555141, RELEM GAO United States General Accounting Oftlce Washingtan, D.C. 20648 Human Resources Division B-249610 August 24, 1992 The Honorable Byron L. Dorgan House of Representatives The... |
| Date July 29, 1992 |
Report No. T-HRD-92-48 |
Title
United States (ieneral Accounting Office
1 Testimony
Before the Select Committee on Narcotics Abuse and Control. House of Representatives For Release: Delivery on Expectedat IO:(W) a.m. Wtxlnt!sday July 29. 1992 MEDICAID PRESCRIPTION DRUG DIVERSION A Major Problem, But State Approaches Offer Some Promise
Statement of Janet L. Shikles, Director Health Financing and Policy Issues Human Resources Div... |
| Date May 4, 1992 |
Report No. GGD-92-72BR |
Title
IJnitcd States General Accounting Office __- -- *”,# & i I I GAO
M ay lW2 Briefing Report to the Chairman, Special Com m ittee on Aging, ITS Senate PHARMACEUTICAL INDUSTRY Tax Benefits of Operating in Puerto Rico
146616 RESTRICTED--Not to be releasbd outside the General Accounting Office unless specifically approved by the Offlce of Congressional Relations. RELEASED GAO United States General Acc... |
| Date April 28, 1992 |
Report No. T-PEMD-92-8 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at IO:00 am., EDT Tuesday, April 28, 1992 Testimony
Before the Subcommittee on Regulation, Business Opportunities and Energy Committee on Small Business House of Representatives OVER THE COUNTER DRUGS Gaps and Potential Vulnerabilities in the Regulatory System
Statement of Kwai-Cheung Chan Director of Program Evaluation i... |
| Date April 8, 1992 |
Report No. T-PEMD-92-5 |
Title
Uniied States General Accounting Office GAO
For releaseon Delivery Expected at IO:00 a.m., EDT Wednesday, April 8, 1992 Testimony
Before the Subcommitteeon Human Resources and Intergovernmental Relations Committee on Government Operations House of Representatives NONPRESCRIPTION DRUGS Over the Counter and Underemphasized
Statementof Kwai-Cheung Chan Director of Program EvaIuation in Physical Syste... |
| Date March 4, 1992 |
Report No. T-RCED-92-36 |
Title
United StatesGeneral Accounting Of&e Testimony
Before the Sub. on Fisheriesand Wildlife Conservationand the Environment, Corn. on Merchant Marine and Fisheries;the Sub. on National Parks and Public Lands, Corn. on Interior and Insular Affairs; and the Sub. on Forests,Family Farmsand Energy, Corn. on Agriculture, House of Representatives
For Release on Delivery Expected at IO:00 a.m., EST Wednesday... |
| Date Jan. 22, 1992 |
Report No. HRD-92-30 |
Title
GAO
*JlltlllllI-y I!)!):! _-- VA HEALTH CXRE Modernizing VA’ s Mail-Service Pharmacies Should Save Millions of Dollars II I
145672 GAO United States General Accounting Office Washington, D.C. 20648 Human Resources Division B-247064 January 22, 1992 The Honorable F’ rank H. Murkowski United States Senate Dear Senator Murkowski: Mail-service pharmacies are playing an increasing role in slowing t... |
| Date Jan. 17, 1992 |
Report No. RCED-92-63 |
Title
.- .._ __.... .__. ._ .._._.... - .,......._. . -._ .- t,44 .-.-I.--.-.-.-~-----~.~ Of’f’iw ^... -........... Sl.;tIJvs (;c~~rc~r;rl Acwbunling --.___ ~I. tIlli..“l-._-.-l-“l.-- -.“-.- --_.-I_-- FOOD SAFETY AND QUALITY FDA Needs Stronger Controls Over the Approval Process for New Animal Drugs GAO unitedstatee General Accounting Offlce
Washington, D.C. 20648 Resources, Community, and Econ... |
| Date Jan. 10, 1992 |
Report No. PEMD-92-9 |
Title
rlltllm-y 199% NONPRESCRIPTION DRUGS Over the Counter and Underemphasized GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-246187 January lo,1992 The Honorable Ron Wyden Chairman, Subcommittee on Regulation, Business Opportunities, and Energy Committee on Small Business House of Representatives Dear Mr. Chairman: In your letter of Feb... |
| Date Sept. 18, 1991 |
Report No. HRD-91-139 |
Title
-l--ll_-.---l- .._.------ -- . ---_-_--_-_~ linikd - States (h~~rt*ral Accounting Office GAO Report to Congressional CorulmitCees Changes in Drug Prices Paid by VA and-DOD Since Enactment of Rebate Provisions GAO United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-246667 September 18, 1991 The Honorable Lloyd Bentsen Chairman, Committee on Finance United State... |
| Date July 22, 1991 |
Report No. PEMD-91-20 |
Title
.Jx~l\, I!)!)1 1 PRESCRIPTION DRUGS Selected Direet-toConsumer Advertising Studies Have Methodological Flaws --. -- . 2 ,,, . . .\ -.-- (;AO/I’ I~MI)-!jl-20 GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-243615
July 22,199l The Honorable John D. Dingell Chairman, Subcommittee on Oversight and Investigations Committee on Energy and... |
